Delco biopharm led by former CEO of AstraZeneca spinoff launches with $150M financing and licensing deal
June 30, 2021 at 11:54 AM EDT
The CEO previously led a biotech firm acquired for $3 billion in March.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|